Navigating the complexities of immunotherapy: unraveling novel targets & pathways

Immuno-Oncology Insights 2023; 4(8), 295–300

DOI: 10.18609/ioi.2023.43

Published: 29 November 2023
Lars van der Veen

Lauren Coyle, Editor, Immuno-Oncology Insights, interviews Lars van der Veen, Founder and CTO of iOnctura to discuss the evolving landscape of novel targets and pathways in the I-O space.